Emerging links between FOXOs and diabetic complications

Area of Science:

• Endocrinology and Metabolism
• Molecular Biology
• Genetics

Background:

• Diabetes mellitus and its complications, including microvascular (nephropathy, retinopathy, neuropathy) and macrovascular (cardiomyopathy) issues, represent a growing global health burden.
• Prolonged hyperglycemia is a primary driver of vascular damage, leading to organ dysfunction and increased mortality.
• The Forkhead Box O (FOXO) family of transcription factors plays crucial roles in cellular processes such as proliferation, metabolism, differentiation, autophagy, and apoptosis.

Purpose of the Study:

• To review the current understanding of the involvement of FOXO transcription factors in the pathogenesis of diabetic complications.
• To highlight the specific roles of FOXO1, FOXO3, FOXO4, and FOXO6 in diabetes-related vascular and organ damage.

Main Methods:

• Literature review of studies investigating FOXO family members in the context of diabetes and its complications.
• Analysis of existing research on the molecular mechanisms linking FOXO activity to hyperglycemia-induced cellular damage.

Main Results:

• Evidence suggests that FOXO transcription factors are implicated in the development and progression of various diabetic complications.
• Dysregulation of FOXO proteins contributes to hyperglycemia-induced damage in both small (microvascular) and large (macrovascular) blood vessels.
• Specific FOXO members (FOXO1, FOXO3, FOXO4, FOXO6) show altered expression or activity in diabetic conditions.

Conclusions:

• FOXO transcription factors are critical regulators in the context of diabetes and its associated complications.
• Targeting FOXO pathways may offer novel therapeutic strategies for managing diabetic complications and reducing diabetes-related mortality.